Live feed/
Filings
/
SCHEDULE
/
0001839882-25-009532
Stake: 41.36%
Shares: 31,322,219
CUSIP: 701455107
Class: Common Stock, Par Value $0.001 per share
Item 4 — Purpose of Transaction
Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On February 14, 2025, Focused Compounding Fund, LP entered into the Purchase Agreements and purchased an aggregate of 867,514 Common Shares at a price of $0.35 per share, for an aggregate purchase price of $303,629.90. The closing of the purchases pursuant to the Purchase Agreements occurred on February 14, 2025.
Cross-References
Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
1 13D/G filings on this issuer
0 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 1.00
5 shares short · -75.0% vs prior
Want this depth on every filing the moment it hits SEC EDGAR?
Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.
Request a pilot →